Network origin in François Meyer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Zurich
38
| College/University | Other Consumer Services | 38 |
Swiss Federal Institute of Technology
27
| College/University | Other Consumer Services | 27 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.
16
| Extinct | Miscellaneous Commercial Services | 16 |
12
| Public Company | Biotechnology | 12 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million.
9
| Extinct | Medical/Nursing Services | 9 |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products.
7
| Subsidiary | Chemicals: Specialty | 7 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland.
4
| Subsidiary | Biotechnology | 4 |
2
| Private Company | Movies/Entertainment | 2 |
BASF Performance Products Ltd. (United Kingdom)
 BASF Performance Products Ltd. (United Kingdom) Chemicals: SpecialtyProcess Industries Basf Performance Products Ltd. manufactures chemical products. It offers dyes and pigments, plastics, and other inorganic basic chemicals. The company was founded on September 12, 1996 and is headquartered in Cheadle, the United Kingdom.
2
| Subsidiary | Chemicals: Specialty | 2 |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.
1
| Government | General Government | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to François Meyer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| UBS | Investment Managers | Corporate Officer/Principal Chairman General Counsel Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | Financial Conglomerates | Director of Finance/CFO Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
Credit Suisse AG
 Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| LONZA GROUP AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SIKA AG | Chemicals: Major Diversified | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Precious Woods Holding AG
 Precious Woods Holding AG Forest ProductsNon-Energy Minerals Precious Woods Holding AG produces and sells logs and sawn timber. The firm also engages in the sustainable management and use of tropical forest. It operates through the following segments: Sustainable Forestry in Brazil, Sustainable Forestry in Gabon, Trading and Carbon and Energy. The Sustainable Forestry in Brazil segment engages in the sustainable management of tropical forests and the processing of tropical timber in Brazil. The Sustainable Forestry in Gabon segment operates in the sustainable management of tropical forests and the processing of tropical timber in Gabon. The Trading segment engages in the trading of timber from external sources in Switzerland. The Carbon & Energy segment engages in the trading of certified emission reductions. The company was founded on December 17, 1990 and is headquartered in Zug, Switzerland. | Forest Products | Director/Board Member Chairman Director/Board Member | |
Pax Holding (Genossenschaft)
 Pax Holding (Genossenschaft) Real Estate DevelopmentFinance Pax Holding (Genossenschaft) is a holding Swiss company with interests in real estate. The private company is based in Basel, Switzerland and has subsidiaries in Switzerland. Peter Kappeler has been the CEO of the company since 2011. | Real Estate Development | Chairman Director/Board Member | |
| Pax Schweizerische Lebensversicherungs AG | Chairman Director/Board Member | ||
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
LCF Communication S.A.
 LCF Communication S.A. Investment ManagersFinance LCF Communication SA provides wealth management services. Its services include banking, asset management, and advisory services. LCF was founded by Baron Edmond de Rothschild in 1953 and is headquartered in Geneva, Switzerland. | Investment Managers | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Energie 360 Grad AG
 Energie 360 Grad AG Gas DistributorsUtilities Energie 360 Grad AG engages in the distribution of natural gas and wooden pellets. The firm invests, constructs, and operates facilities for the use of renewable energies. It also offers solutions and consulting services in the areas of heating, solar energy, water supply, electricity generation and network services. The company was founded in 1998 and is headquartered in Zurich, Switzerland. | Gas Distributors | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
| University of St. Gallen | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of Amsterdam | College/University | Doctorate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
| University of Groningen | College/University | Doctorate Degree Undergraduate Degree | |
| University of Basel | College/University | Director/Board Member Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Fribourg | College/University | Graduate Degree Undergraduate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor Founder | |
Swiss-American Chamber of Commerce
 Swiss-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Morandini AG
 Morandini AG Real Estate DevelopmentFinance Part of Bâloise Holding AG, Morandini AG is a Swiss company that owns, manages, and sells real estate properties. The company is based in Basel, Switzerland. Morandini was acquired by Artires AG on August 31, 2009. | Real Estate Development | Chairman Corporate Officer/Principal | |
| JULIUS BÄR GRUPPE AG | Financial Conglomerates | Director/Board Member Public Communications Contact | |
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Director/Board Member | |
| Mercuri Urval AG | Director/Board Member Director/Board Member | ||
| PAX Wohnbauten AG | Chief Executive Officer Director/Board Member | ||
| Spiess & Partner | Corporate Officer/Principal General Counsel | ||
| PAX-Liegenschaften AG | Chairman Director/Board Member | ||
| PAX Immotrade AG | Chief Executive Officer Director/Board Member | ||
| PAX Invest AG | Chairman Director/Board Member | ||
| PAX Real Estate AG | Chairman Director/Board Member | ||
| PAX Construct AG | Chairman Director/Board Member | ||
| Immotest Bau- & Verwaltungs-AG | Director/Board Member Chairman | ||
| Oxyrane, Ltd. | Chairman Director/Board Member | ||
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Founder Chairman |
Statistics
International
| Switzerland | 33 |
| United States | 7 |
| Netherlands | 6 |
| France | 3 |
| Germany | 2 |
Sectoral
| Finance | 13 |
| Health Technology | 12 |
| Consumer Services | 10 |
| Miscellaneous | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 534 |
| Corporate Officer/Principal | 241 |
| Chairman | 178 |
| Chief Executive Officer | 71 |
| Independent Dir/Board Member | 64 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick K. Oesch | 43 |
| Ralph Max Büchi | 41 |
| Ernst Brugger | 35 |
| Hugo Slootweg | 34 |
| Niklaus Peter Nüesch | 29 |
| Steven Holtzman | 28 |
| Max E. Link | 28 |
| Rudolf Wehrli | 25 |
| Ferdinand Verdonck | 25 |
| Heinrich Andreas Baumann | 24 |
| Jean Bizzari | 24 |
| Thomas Wetzel | 23 |
| Joseph Feczko | 23 |
| Antonio Matteo Taormina | 22 |
| Bernhard M. Hammer | 20 |
- Stock Market
- Insiders
- François Meyer
- Company connections
